Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Clinical trial NCT01031069 · COMPLETED

Trial details

NCT number: NCT01031069
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Infections, Papillomavirus Papillomavirus Vaccines

Start date: 2010-10-26
Primary completion: 2016-01-13
Enrollment: 873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.